Biotage Management
Management criteria checks 3/4
Biotage's CEO is Torben Jorgensen, appointed in Jan 2024, has a tenure of less than a year. directly owns 0.4% of the company’s shares, worth SEK53.79M. The average tenure of the management team and the board of directors is 3.3 years and 2.4 years respectively.
Key information
Torben Jorgensen
Chief executive officer
kr857.0k
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | 0.4% |
Management average tenure | 3.3yrs |
Board average tenure | 2.4yrs |
Recent management updates
Recent updates
Revenue Beat: Biotage AB (publ) Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates
Apr 28Biotage's (STO:BIOT) Dividend Will Be SEK1.60
Apr 17Biotage AB (publ) Just Beat EPS By 53%: Here's What Analysts Think Will Happen Next
Apr 08Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60
Apr 03Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60
Mar 04Weak Statutory Earnings May Not Tell The Whole Story For Biotage (STO:BIOT)
Feb 22Subdued Growth No Barrier To Biotage AB (publ) (STO:BIOT) With Shares Advancing 32%
Feb 21Biotage AB (publ) Just Recorded A 53% EPS Beat: Here's What Analysts Are Forecasting Next
Feb 18Biotage (STO:BIOT) Has A Pretty Healthy Balance Sheet
Feb 08Investors Still Waiting For A Pull Back In Biotage AB (publ) (STO:BIOT)
Jan 07At kr124, Is It Time To Put Biotage AB (publ) (STO:BIOT) On Your Watch List?
Dec 08Estimating The Intrinsic Value Of Biotage AB (publ) (STO:BIOT)
Oct 27Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?
Jul 12An Intrinsic Calculation For Biotage AB (publ) (STO:BIOT) Suggests It's 26% Undervalued
Jun 08Biotage (STO:BIOT) Ticks All The Boxes When It Comes To Earnings Growth
May 24Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's
Apr 05These 4 Measures Indicate That Biotage (STO:BIOT) Is Using Debt Safely
Mar 12Is It Too Late To Consider Buying Biotage AB (publ) (STO:BIOT)?
Feb 21Are Biotage AB (publ) (STO:BIOT) Investors Paying Above The Intrinsic Value?
Jan 06Biotage (STO:BIOT) Seems To Use Debt Rather Sparingly
Dec 03Is Now The Time To Look At Buying Biotage AB (publ) (STO:BIOT)?
Oct 27Estimating The Fair Value Of Biotage AB (publ) (STO:BIOT)
Oct 07Biotage (STO:BIOT) Could Easily Take On More Debt
Sep 03Is There Now An Opportunity In Biotage AB (publ) (STO:BIOT)?
Jul 10A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)
Jun 25Do Biotage's (STO:BIOT) Earnings Warrant Your Attention?
May 28Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's
Apr 23Biotage (STO:BIOT) Is Paying Out A Larger Dividend Than Last Year
Mar 29Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?
Mar 14Is It Time To Consider Buying Biotage AB (publ) (STO:BIOT)?
Feb 28Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's
Feb 13A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)
Jan 23Is Biotage (STO:BIOT) A Risky Investment?
Dec 10Is Now The Time To Put Biotage (STO:BIOT) On Your Watchlist?
Nov 03Biotage (STO:BIOT) Has A Rock Solid Balance Sheet
Aug 17Is Now The Time To Put Biotage (STO:BIOT) On Your Watchlist?
Jul 24CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Mar 31 2024 | n/a | n/a | kr236m |
Dec 31 2023 | kr857k | n/a | kr246m |
Sep 30 2023 | n/a | n/a | kr189m |
Jun 30 2023 | n/a | n/a | kr216m |
Mar 31 2023 | n/a | n/a | kr240m |
Dec 31 2022 | kr817k | n/a | kr268m |
Sep 30 2022 | n/a | n/a | kr240m |
Jun 30 2022 | n/a | n/a | kr228m |
Mar 31 2022 | n/a | n/a | kr216m |
Dec 31 2021 | kr732k | n/a | kr205m |
Sep 30 2021 | n/a | n/a | kr203m |
Jun 30 2021 | n/a | n/a | kr187m |
Mar 31 2021 | n/a | n/a | kr174m |
Dec 31 2020 | kr2m | kr1m | kr175m |
Sep 30 2020 | n/a | n/a | kr149m |
Jun 30 2020 | n/a | n/a | kr179m |
Mar 31 2020 | n/a | n/a | kr201m |
Dec 31 2019 | kr7m | kr3m | kr187m |
Sep 30 2019 | n/a | n/a | kr196m |
Jun 30 2019 | n/a | n/a | kr173m |
Mar 31 2019 | n/a | n/a | kr170m |
Dec 31 2018 | kr7m | kr3m | kr168m |
Sep 30 2018 | n/a | n/a | kr175m |
Jun 30 2018 | n/a | n/a | kr162m |
Mar 31 2018 | n/a | n/a | kr148m |
Dec 31 2017 | kr6m | kr3m | kr139m |
Compensation vs Market: Torben's total compensation ($USD77.92K) is below average for companies of similar size in the Swedish market ($USD789.18K).
Compensation vs Earnings: Torben's compensation has been consistent with company performance over the past year.
CEO
Torben Jorgensen (71 yo)
less than a year
Tenure
kr857,000
Compensation
Mr. Torben Jorgensen, B.Sc. serves as President at Biotage AB form January 04, 2024 and serves as its as CEO since 2024 and served as its as Interim CEO since January 04, 2024 until 2024 and served as its...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, President & Director | less than a year | kr857.00k | 0.40% SEK 53.8m | |
Chief Financial Officer | less than a year | no data | no data | |
Executive Vice President of Operations | 14yrs | no data | 0.0064% SEK 864.3k | |
EVP of Global Marketing | no data | no data | no data | |
Chief Human Resources & Sustainability Officer | no data | no data | 0.019% SEK 2.5m | |
President of Americas & Chief/Head of Americas | no data | no data | 0.0064% SEK 864.3k | |
Chief Auditor | no data | no data | no data | |
Executive Vice President of Business Development | no data | no data | 0.025% SEK 3.4m | |
President of International - EMEA and APAC | 3.9yrs | no data | 0.0064% SEK 864.3k | |
Executive Vice President of IT & Digitalization | no data | no data | 0.0059% SEK 787.7k | |
Executive Vice President of Quality Assurance & Regulatory Affairs | 3.3yrs | no data | no data | |
Executive Vice President R&D | no data | no data | no data |
3.3yrs
Average Tenure
51.5yo
Average Age
Experienced Management: BIOT's management team is considered experienced (3.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO, President & Director | 4.5yrs | kr857.00k | 0.40% SEK 53.8m | |
Chairman | 1.1yrs | kr227.00k | no data | |
Director | 11.1yrs | kr407.00k | 0.020% SEK 2.7m | |
Director | 4.5yrs | kr337.00k | no data | |
Director | 5.1yrs | kr307.00k | no data | |
Director | 1.1yrs | no data | no data | |
Employee Representative Director | 2.4yrs | no data | no data | |
Director | 2.1yrs | kr357.00k | no data | |
Employee Representative Director | no data | no data | no data | |
Employee Representative Director | less than a year | no data | no data |
2.4yrs
Average Tenure
60.5yo
Average Age
Experienced Board: BIOT's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.